Wold, W.S. and Toth, K., Adenovirus vectors for gene therapy, vaccination and cancer gene therapy, Curr. Gene Ther., 2013, vol. 13, pp. 421–433.
He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B., A simplified system for generating recombinant adenoviruses, Proc. Natl. Acad. Sci. U. S. A., 1998, vol. 95, pp. 2509–2514.
Luo, J., Deng, Z.L., Luo, X., Tang, N., Song, W.X., Chen, J., et al., A protocol for rapid generation of recombinant adenoviruses using the AdEasy system, Nat. Protoc., 2007, vol. 2, pp. 1236–1247.
Zeng, M., Smith, S.K., Siegel, F., Shi, Z., Van Kampen, K.R., Elmets, C.A., et al., AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination, BioTechniques, 2001, vol. 31, pp. 260–262.
Miravet, S., Ontiveros, M., Piedra, J., Penalva, C., Monfar, M., and Chillon, M., Construction, production, and purification of recombinant adenovirus vectors, Methods Mol. Biol., 2014, vol. 1089, pp. 159–173.
Reddy, P.S., Ganesh, S., Hawkins, L., and Idamakanti, N., Generation of recombinant adenovirus using the Escherichia coli BJ5183 recombination system, Methods Mol. Med., 2007, vol. 130, pp. 61–68.
Wedeken, L., Ohnheiser, J., Hirschi, B., Wethkamp, N., and Klempnauer, K.H., Association of tumor suppressor protein Pdcd with ribosomes is mediated by protein-protein and protein-RNA interactions, Genes Cancer, 2010, vol. 1, pp. 293–301.
Cotteret, S. and Chernoff, J., Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties, Mol. Cell. Biol., 2006, vol. 26, pp. 3215–3230.
Titus, D.E., Promega Protocols and Applications Guide,Madison, WI: Promega Corp., 1991.
Shepelev, M.V., Chernoff, J., and Korobko, I.V., Rho family GTPase Chp/RhoV induces PC12 apoptotic cell death via JNK activation, Small GTPases, 2011, vol. 2, pp. 17–26.
